- Home
- CRDL vs IMPP Comparison
CRDL vs IMPP Comparison
Compare CRDL & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- IMPP
- Stock Information
- Founded
- CRDL 2017
- IMPP 1981
- Country
- CRDL Canada
- IMPP Greece
- Employees
- CRDL N/A
- IMPP N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- IMPP Marine Transportation
- Sector
- CRDL Health Care
- IMPP Consumer Discretionary
- Exchange
- CRDL Nasdaq
- IMPP Nasdaq
- Market Cap
- CRDL 112.4M
- IMPP 103.9M
- IPO Year
- CRDL N/A
- IMPP N/A
- Fundamental
- Price
- CRDL $1.44
- IMPP $3.14
- Analyst Decision
- CRDL Strong Buy
- IMPP
- Analyst Count
- CRDL 2
- IMPP 0
- Target Price
- CRDL $9.00
- IMPP N/A
- AVG Volume (30 Days)
- CRDL 289.4K
- IMPP 131.7K
- Earning Date
- CRDL 08-11-2025
- IMPP 08-26-2025
- Dividend Yield
- CRDL N/A
- IMPP N/A
- EPS Growth
- CRDL N/A
- IMPP N/A
- EPS
- CRDL N/A
- IMPP 1.21
- Revenue
- CRDL N/A
- IMPP $138,368,325.00
- Revenue This Year
- CRDL N/A
- IMPP $8.79
- Revenue Next Year
- CRDL N/A
- IMPP $40.11
- P/E Ratio
- CRDL N/A
- IMPP $2.59
- Revenue Growth
- CRDL N/A
- IMPP N/A
- 52 Week Low
- CRDL $0.77
- IMPP $2.12
- 52 Week High
- CRDL $2.63
- IMPP $4.55
- Technical
- Relative Strength Index (RSI)
- CRDL 56.90
- IMPP 50.23
- Support Level
- CRDL $1.14
- IMPP $2.99
- Resistance Level
- CRDL $1.42
- IMPP $3.29
- Average True Range (ATR)
- CRDL 0.10
- IMPP 0.12
- MACD
- CRDL 0.01
- IMPP -0.01
- Stochastic Oscillator
- CRDL 83.33
- IMPP 47.06
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.